Nelly Group AB (FRA:CD20) Research & Development: €0.0 Mil (TTM As of Mar. 2026)


FRA:CD20 Nelly Group AB FRA:CD20
60 GF Score
Price €3.07
GF Value €3.01
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Nelly Group AB Research & Development?

Nelly Group AB FRA:CD20 +2.33% 60 Research & Development is €0.0 Mil as of Mar. 2026. GuruFocus rates FRA:CD20 with a GF Score™ of 60/100 and a GF Value™ of €3.01 (Fairly Valued). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Nelly Group AB's Research & Development for the three months ended in Mar. 2026 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0.0 Mil.

Nelly Group AB  (FRA:CD20) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Nelly Group AB Research & Development Related Terms

Nelly Group AB Research & Development Historical Data

* Premium members only.

The historical data trend for Nelly Group AB's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nelly Group AB Research & Development Chart

Nelly Group AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Nelly Group AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:CD20
60GF Score
Nelly Group AB FRA:CD20
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nelly Group AB Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.0 Mil mean?
Nelly Group AB (FRA:CD20) has a Research & Development of €0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Nelly Group AB and its competitors.
Is Nelly Group AB's Research & Development too high?
Nelly Group AB's current Research & Development is €0.0 Mil. Overall, Nelly Group AB has a GF Score™ of 60/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nelly Group AB's Research & Development compare to TJX and ROST?
Nelly Group AB's Research & Development of €0.0 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Retail - Cyclical company?
A good Research & Development depends on the Retail - Cyclical industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Nelly Group AB and its competitors. Nelly Group AB's current Research & Development is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nelly Group AB stock overvalued right now?
Based on GuruFocus' analysis, Nelly Group AB (FRA:CD20) is currently considered Fairly Valued. The stock's GF Value™ is €3.01, compared to a current price of €3.07 — trading 2% above its estimated fair value. The current Research & Development is €0.0 Mil. Nelly Group AB's overall GF Score™ is 60/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Nelly Group AB (FRA:CD20), the current Research & Development is €0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nelly Group AB (FRA:CD20) Overvalued in 2026?

Based on GuruFocus' analysis, Nelly Group AB stock appears to be overvalued. The current stock price of €3.07 is trading 2% above its estimated GF Value™ of €3.01. GuruFocus considers Nelly Group AB to be Fairly Valued.

Key valuation signals for FRA:CD20:

  • Research & Development: €0.0 Mil
  • GF Value™: €3.01 vs. price of €3.07 (2% above fair value)
  • GF Score™: 60/100 with 3 warning signs

No single metric tells the full story. See the FRA:CD20 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nelly Group AB Business Description

Address c/o Nelly NLY AB, Lundbygatan 1, P.O. Box 690, Boras, SWE, 501 13
Nelly Group AB is active in the retail industry. The company offers a wide range of fashion and accessories to mainly young women in the Nordic region. At the core is the own brand Nelly, which is marketed and sold in combination with a well-composed portfolio of external brands. The company sells directly to its target group via digital customers, mainly Nelly.com. Geographically, the company generates a majority of its revenue from Sweden, and the rest from Other Nordic regions, and the Rest of the world.
60GF Score

Get the complete analysis for FRA:CD20

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.07
Price
€3.01
GF Value